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background:  This study aimed to characterize in vivo drug delivery using the Agent paclitaxel coated PTCA balloon (Boston Scientific 
Corporation, MN) and endothelialization in relation to the morphological distribution of paclitaxel.
methods:  Bilateral endothelial denudation was followed by deployment of drug-coated balloon (Agent, 3.0 x 15mm) or plain control balloon 
at nominal pressure in iliac arteries (n=20) of healthy rabbits. The Agent TransPAX coating system employing paclitaxel/excipient (2ug/
mm2 dose density) was used in 15 arteries. Controls consisted of uncoated EMERGE balloon (“POBA”, n=5). Vessels were bisected 
longitudinally and exposed to an antibody staining against paclitaxel and CD31 or tubulin and a fluorescently labeled secondary antibody. 
Analysis was performed by confocal microscopy at 15 minutes, 1 day, 3 days, 7 days and 14 days.
results: Anti- Paclitaxel positive area was highest after 15 minutes (6.12 mm2) and decreased over time in DCB treated arteries up to 
14 days (3.77 mm2). Endothelium expressing CD31 was lowest at 15 minutes (2.86 mm2) and increased up to 14 days (57.04 mm2). 
Paclitaxel was found to co-localize with connective tissue at early and with endothelium at later time points.
Conclusion:  This animal model enables to investigate the efficacy of drug delivery after deployment of the Agent DCB . Simultaneous 
staining for CD31 and paclitaxel can be used to colocalize drug in relation to endothelial cells and to characterize dynamic changes over 
time during healing.
